Objective: To find out if there is any association between ABO and Rh blood groups and pregnancy-induced hypertensive (PIH) disorders, i.e. gestational hypertension (GH), preeclampsia (PE) and eclampsia (E).
INTRODUCTION
Hypertensive disorders of pregnancy are the most common medical problem encountered during pregnancy and are the leading cause of maternal as well as perinatal morbidity and mortality worldwide. These can be in the form of gestational hypertension (GH), pre-eclampsia (PE) or eclampsia (E). All these hypertensive disorders affect approximately 5 to 10% of all pregnancies. In India, its incidence ranges from 5 to 15% (16% in primigravidas and 7% in multigravidas). 1 Globally, approximately 800 women die due to pregnancy-related complications every day. 2 In India, roughly one maternal death occur every 5 minutes. 3 Sixteen percent of all maternal deaths occur due to gestational hypertensive disorders. 4 While in developing countries, of all pregnancy-induced hypertensive (PIH) disorders, majority of deaths result due to E, in developed countries, complications of severe PE are more often the cause. 5 Pre-eclampsia is a multisystem disorder of unknown etiology and its development is influenced by both genetic and environmental risk factors. These risk factors include nulliparity, history of raised blood pressure (BP), pre-existing diabetes, multiple pregnancy and raised pre-pregnancy body mass index (BMI). 6, 7 In view of blood group as a risk factor for PE, it is suspected that PE may result from changes in vascular function, 8 influenced by ABO blood group. ABO blood group, an easily accessible factor in a person's genetic make-up, may play a major role in interaction of immune and coagulation systems by influencing gene-environment interactions. There are different studies which support the association between ABO and Rh blood groups and PIH disorders. 9,10 So, we undertook this study to find out if there is any relation between ABO system and PIH disorders among Indian population. 
MATERIALS AND METHODS

Eclampsia
• Seizures that cannot be attributed to other causes in a woman with PE. Exclusion criteria's were-multiple pregnancy, primigravidas with other medical disease or condition likely to affect the pregnancy outcome, i.e. chronic hypertension, diabetes, renal or collagen vascular diseases, thyroid disorders, smoking or any drug use and any congenital fetal anomalies.
STATISTICAL ANALYSIS
The data were analyzed by using Microsoft Excel and Statistical Package of Social Sciences (SPSS). Categorical data analysis for comparison of percentages was performed with Chi-square contingency table analysis. Blood group O was taken as reference due to absence of both 'A' and 'B' antigens. The association of blood groups with different categories of PIH was estimated by calculating odds ratio from logistic regression models using blood group O as a reference. A 'p' value of < 0.05 was considered as statistically significant.
RESULTS
A total of 1964 primigravidas were identified during this period of which 324 were diagnosed with PIH. Of these, only 286 patients met the strict inclusion criteria and included for analysis as shown in Flow Chart 1. Among 286 primigravidas with PIH, 16 were Rh negative. Here, we found the prevalence of PIH in primigravidas was 14.56% of which 8.45% (166 cases) were diagnosed with gestational hypertension, 2.55% (50 cases) with PE and 3.56% (70 cases) with eclampsia. Among our study group, the major blood group was B (38.5%) followed by O (26.6%), A (19.6%) and AB (15.4%), among which 94.4% were RhD positive. The mean age at delivery was 23.43 years with SD of 3.39. The characteristic distribution of women included in our study group are displayed in Table 1 . Most patients were less than 30 years of age (91.6%) and at gestational age ≥ 37 weeks (80.4%) at the time of admission. Among different categories of PIH disorders, more than half were diagnosed with GH (58%). Blood group B was most common, whereas AB was least common and majority were of Rh positive blood group.
In Graph 1, frequency distribution of different categories of PIH among different blood groups can be seen.
In Table 2 , with the help of Chi-square test, it was observed that gestational age of pregnancy and blood groups have a significant association with PIH disorders. However, no association was found between Rh typing and PIH disorders.
In Table 3 , taking blood group O as a reference, we found that blood group A has 50% more risk of developing PE [OR = 1.500 (0.638-3.528)]. Blood group AB has five times highest risk of developing E [OR = 4.889 (2.012-11.879)] as compared to O blood group. The trend of increasing odds ratio with severity of disease outcome was obvious for all non-O blood groups, i.e. AB, A and B.
In Graph 2, we can see that among majority of patients diagnosed with GH, the raised BP was subsided after delivery, whereas in PE and E, most of the patients needed treatment even after delivery.
DISCUSSION
The results of our study indicate that primigravidas with AB blood group have highest risk of developing PIH disorders as compared to other blood groups. This finding is consistent with findings of Lee et al, 9 Hiltunen et al, 10 Bharali et al, 11 Phaloprakarn et al. 
JSAFOG
Of several hypothesis regarding association of blood groups with PIH disorders, one suggested mechanism is through maternal immune response. As per recent view on PE, it is suggested that these patients have exaggregated maternal systemic immune response and characteristic changes in coagulation systems, differences in blood group may increase the risk of disease. A study concluded that placental protein 13 (PP13), an early biomarker of PE, primarily produced by placenta has strongest affinity to blood group AB. In women with AB blood group, the close proximity of A and B antigens can explain the stronger binding of PP13 to blood group AB erythrocytes leading to its sequestration. Thus, low level of 1st trimester maternal serum PP13 could predispose to PIH disorders. 13, 14 In addition, compared with blood group O, non-O (A, B, AB) blood groups are associated with an increased risk of thrombotic events, though this relationship is not confirmed. It may be due to the effect of von Willebrand factor (vWf), which was found higher in non-O (A, B, AB) blood group patients compared with blood group O. 15 Evidence suggests that vWf may promote platelet aggregation or adhesion and atherosis formation leading to endothelial dysfunction, a factor considered in pathogenesis of PE.
16,17
A variety of inflammatory markers associated with PE, like tumor necrosis factor-alpha and soluble intercellular adhesion molecule 1 were found to be upregulated at ABO locus through polymorphism. According to a recent study, of diverse panel of inflammatory biomarkers-E-selectin, P-selectin and ICAM-1, 18 only E-selectin levels were found to be higher in PE cases vs controls. 19 But, the role of blood groups in PIH cannot be concluded without a proper investigation of paternal blood group and its association. Another limitation of this study was as there is no water-tight compartment between different categories of PIH, some cases of mild PE that might have progressed to severe PE or E, no records of their progression could be make out. And being a retrospective study of patient records, we were not able to make out cases of severe PE or imminent E, which is based more on clinical symptoms, and their association.
To summarize, though of modest sample size due to strict inclusion-exclusion criteria, our observations appear to have biological plausibility. The findings suggest an association between ABO blood groups and PIH in primigravidas among our population and support the hypothesis that genetic factors related to distribution of blood groups may play a role in development of hypertensive disorders of pregnancy. Hence, special attention should be given to primigravidas with AB blood group to prevent the complications of PIH and improve the prognosis. Although some strong risk factors for PE have been identified, the etio-pathogenesis is still poorly understood, and many recent research effort is being directed at investigating these biomarkers. 20, 21 
